Ross
Wallace,
Santis Health
(Consultant)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
Canadian Biosimilars Forum
Consultant:
Ross Wallace
Designated Public Office Holders who participated in the communication:
-
Cathy Parker,
Director General
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Kelly Robinson,
Director
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Anthony Ridgway,
Senior Regulatory Scientist
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Agnes Klein,
Senior Medical Advisor
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Georgette Roy,
Director, Office of Regulatory Affairs
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Liz Anne Gillham-Eisen,
A Director
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Stephanie Hardy,
Manager, Policy Unit
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Jian Wang,
Division Chief
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Lindsay Elmgren,
Director, Centre for Biologics Evaluation
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Emily Griffiths,
Subject Matter / Technical Specialist
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Michele Chadwick,
Manager
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Megan Bettle,
Director
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Johanne Veenstra,
Senior Regulatory Officer
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Evelyn Soo,
Associate to the Director General
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Jemma Fraije,
A/ Regulatory Affairs Supervisor
| Health Products and Therapeutics Branch
|
Health Canada (HC)
-
Karen Reynolds,
Executive Director
| Strategic Policy Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2018-05-22
Posted date:
2018-06-15
Communication number:
358995-429091
View associated registration
-
Canadian Biosimilars Forum
Consultant:
Ross Wallace
Designated Public Office Holders who participated in the communication:
-
Cathy Parker,
Director General
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Anthony Ridgway,
Acting Director
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Agnes Klein,
Senior Medical Advisor, DGO
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Jeffrey Skene,
Division Chief
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Wallace Lauzon,
Division Chief
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Jian Wang,
Division Chief
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Georgette Roy,
Director
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Sandra Alderdice,
Regulatory Affairs Supervisor
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Liz Anne Gillham-Eiosen,
A Director
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Stephanie Hardy,
Manager, Policy Unit
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Parag Buch,
Subject Matter Technical Special
| MARKETED HEALTH PRODUCTS DIRECTORATE
|
Health Canada (HC)
-
Andrea Bedard,
Policy Analyst
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Michele Chadwick,
Manager
| BIOLOGICS AND GENETIC THERAPIES DIRECTORATE
|
Health Canada (HC)
-
Laura Johnson,
SBD Project Manager
| THERAPEUTIC PRODUCTS DIRECTORATE
|
Health Canada (HC)
-
Alain Musende,
Manager
| MARKETED HEALTH PRODUCTS DIRECTORATE
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2017-11-21
Posted date:
2018-01-17
Communication number:
358995-418390
View associated registration
-
Canadian Biosimilars Forum
Consultant:
Ross Wallace
Designated Public Office Holders who participated in the communication:
-
Cathy Parker,
Director General
| Health Products and Food Branch
|
Health Canada (HC)
-
Anthony Ridgway,
Acting Director
| Health Products and Food Branch
|
Health Canada (HC)
-
Agnes Klein,
Senior Medical Advisor
| Health Products and Food Branch
|
Health Canada (HC)
-
Jeffrey Skene,
Division Chief
| Health Products and Food Branch
|
Health Canada (HC)
-
Wallace Lauzon,
Division Chief
| Health Products and Food Branch
|
Health Canada (HC)
-
Jian Wang,
Division Chief
| Health Products and Food Branch
|
Health Canada (HC)
-
Catherine Njue,
Biostatistician Advisor - Clinical Trials
| Health Products and Food Branch
|
Health Canada (HC)
-
Georgette Roy,
Director, Office of Regulatory Affairs
| Health Products and Food Branch
|
Health Canada (HC)
-
Sandra Alderdice,
Regulatory Affairs Supervisor
| Health Products and Food Branch
|
Health Canada (HC)
-
Liz Anne Gillham-Eisen,
A/Director
| Health Products and Food Branch
|
Health Canada (HC)
-
Stephanie Hardy,
Manager, Policy Unit
| Health Products and Food Branch
|
Health Canada (HC)
-
Nick Orphanos,
Senior Policy Analyst
| Health Products and Food Branch
|
Health Canada (HC)
-
Emily Griffiths,
Policy Analyst
| Health Products and Food Branch
|
Health Canada (HC)
-
Ashley Baer,
Policy Analyst
| Health Products and Food Branch
|
Health Canada (HC)
-
Deryck Trehearne,
Director General
| Health Products and Food Branch
|
Health Canada (HC)
-
Trish Larwill,
Senior Policy Advisor
| Health Products and Food Branch
|
Health Canada (HC)
-
Michele Chadwick,
Manager
| Health Products and Food Branch
|
Health Canada (HC)
-
Laura Johnson,
SBD Project Manager
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2017-06-09
Posted date:
2017-08-04
Communication number:
358995-404276
View associated registration
-
Canadian Biosimilars Forum
Consultant:
Ross Wallace
Designated Public Office Holders who participated in the communication:
-
Catherine Parker,
Director General
| Health Products and Food Branch
|
Health Canada (HC)
-
Anthony Ridgway,
Acting Director
| Health Products and Food Branch
|
Health Canada (HC)
-
Agnes Klein,
Director
| Health Products and Food Branch
|
Health Canada (HC)
-
Jeffrey Skene,
Division Chief
| Health Products and Food Branch
|
Health Canada (HC)
-
Wallace Lauzon,
Division Chief
| Health Products and Food Branch
|
Health Canada (HC)
-
Jian Wang,
Division Chief
| Health Products and Food Branch
|
Health Canada (HC)
-
Catherine Njue,
Biostatistician Advisor - Clinical Trials
| Health Products and Food Branch
|
Health Canada (HC)
-
Georgette Roy,
Director, Office of Regulatory Affairs
| Health Products and Food Branch
|
Health Canada (HC)
-
Sandra Alderdice,
Regulatory Affairs Supervisor
| Health Products and Food Branch
|
Health Canada (HC)
-
Liz Anne Gillham-Eisen,
A/Director
| Health Products and Food Branch
|
Health Canada (HC)
-
Stephanie Hardy,
Manager, Policy Unit
| Health Products and Food Branch
|
Health Canada (HC)
-
Bobby Chauhan,
Senior Regulatory Officer
| Health Products and Food Branch
|
Health Canada (HC)
-
Andrea Bedard,
Policy Analyst
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2016-11-22
Posted date:
2016-12-15
Communication number:
358995-391145
View associated registration